Application of new technology in bladder cancer diagnosis and treatment

World Journal of Urology

Volumn 27, Issue 3, 2009, Pages 301-307

  Goh, Alvin C ^a   Lerner, Seth P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

5 Aminolevulinic acid; Bladder cancer; Fluorescence; Narrow band imaging; Optical coherence tomography; Virtual cystoscopy

Indexed keywords

ARTICLE; BLADDER TUMOR; CYSTOSCOPY; FLUORESCENCE; HUMAN; METHODOLOGY;

CYSTOSCOPY; FLUORESCENCE; HUMANS; URINARY BLADDER NEOPLASMS;

EID: 67349266582     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-009-0387-z     Document Type: Article

References (53)

1. Riley GF, Potosky AL, Lubitz JD, Kessler LG (1995) Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care 33(8):828-841
2. Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R (2003) The health economics of bladder cancer: A comprehensive review of the published literature. Pharmacoeconomics 21(18):1315-1330
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2):71-96
4. Herr HW (1997) Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients. World J Urol 15(2):84-88
5. Holmang S, Hedelin H, Anderstrom C, Holmberg E, Busch C, Johansson SL (1999) Recurrence and progression in low grade papillary urothelial tumors. J Urol 162(3 Pt 1):702-707
6. Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, Witjes JA, Newling D, Bouffioux C, Sylvester RJ (2002) Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies. Eur Urol 41(5):523-531
7. Quayle SS, Ames CD, Lieber D, Yan Y, Landman J (2005) Comparison of optical resolution with digital and standard fiberoptic cystoscopes in an in vitro model. Urology 66(3):489-493
8. Cina SJ, Epstein JI, Endrizzi JM, Harmon WJ, Seay TM, Schoenberg MP (2001) Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder. Hum Pathol 32(6):630-637
9. Soloway MS, Murphy W, Rao MK, Cox C (1978) Serial multiple-site biopsies in patients with bladder cancer. J Urol 120(1):57-59
10. Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodriguez J (2000) Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 163(1):73-78
11. Klan R, Loy V, Huland H (1991) Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol 146(2):316-318
12. Schwaibold HE, Sivalingam S, May F, Hartung R (2006) The value of a second transurethral resection for T1 bladder cancer. BJU Int 97(6):1199-1201
13. Brauers A, Buettner R, Jakse G (2001) Second resection and prognosis of primary high risk superficial bladder cancer: Is cystectomy often too early? J Urol 165(3):808-810
14. Shariat SF, Palapattu GS, Karakiewicz PI, Rogers CG, Vazina A, Bastian PJ, Schoenberg MP, Lerner SP, Sagalowsky AI, Lotan Y (2007) Discrepancy between clinical and pathologic stage: Impact on prognosis after radical cystectomy. Eur Urol 51(1):137-149 (discussion 149-151)
15. Whitmore WF Jr, Bush IM, Esquivel E (1964) Tetracycline Ultraviolet Fluorescence in Bladder Carcinoma. Cancer 17:1528-1532
16. Kelly JF (1975) Haematoporphyrins in the diagnosis and treatment of carcinoma of the bladder. Proc R Soc Med 68(8):527-528
17. Kennedy JC, Pottier RH, Pross DC (1990) Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience. J Photochem Photobiol B 6(1-2):143-148
18. Lavie G, Mazur Y, Lavie D, Meruelo D (1995) The chemical and biological properties of hypericin-a compound with a broad spectrum of biological activities. Med Res Rev 15(2):111-119
19. Batlle AM (1993) Porphyrins, porphyrias, cancer and photodynamic therapy - a model for carcinogenesis. J Photochem Photobiol B 20(1):5-22
20. Hungerhuber E, Stepp H, Kriegmair M, Stief C, Hofstetter A, Hartmann A, Knuechel R, Karl A, Tritschler S, Zaak D (2007) Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Urology 69(2):260-264
21. Jichlinski P, Guillou L, Karlsen SJ, Malmstrom PU, Jocham D, Brennhovd B, Johansson E, Gartner T, Lange N, van den Bergh H, Leisinger HJ (2003) Hexyl aminolevulinate fluorescence cystoscopy: New diagnostic tool for photodiagnosis of superficial bladder cancer-a multicenter study. J Urol 170(1):226-229
22. Jocham D, Witjes F, Wagner S, Zeylemaker B, van Moorselaar J, Grimm MO, Muschter R, Popken G, Konig F, Knuchel R, Kurth KH (2005) Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: A prospective, phase III multicenter study. J Urol 174(3):862-866 (discussion 866)
23. Grossman HB, Gomella L, Fradet Y, Morales A, Presti J, Ritenour C, Nseyo U, Droller MJ (2007) A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol 178(1):62-67
24. Schmidbauer J, Witjes F, Schmeller N, Donat R, Susani M, Marberger M (2004) Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 171(1):135-138
25. Fradet Y, Grossman HB, Gomella L, Lerner S, Cookson M, Albala D, Droller MJ (2007) A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: A phase III, multicenter study. J Urol 178(1):68-73 (discussion 73)
26. Liu H, Wu M, Thomas YK, Lerner SP (2008) Fluorescence and white light cystoscopy for detecting carcinoma in situ of the bladder. J Urol 179(4):326
27. Filbeck T, Pichlmeier U, Knuechel R, Wieland WF, Roessler W (2002) Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors. J Urol 168(1):67-71
28. Riedl CR, Daniltchenko D, Koenig F, Simak R, Loening SA, Pflueger H (2001) Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer. J Urol 165(4):1121-1123
29. Daniltchenko DI, Riedl CR, Sachs MD, Koenig F, Daha KL, Pflueger H, Loening SA, Schnorr D (2005) Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol 174(6):2129-2133 (discussion 2133)
30. Denzinger S, Burger M, Walter B, Knuechel R, Roessler W, Wieland WF, Filbeck T (2007) Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. Urology 69(4):675-679
31. Steinbach P, Weingandt H, Baumgartner R, Kriegmair M, Hofstadter F, Knuchel R (1995) Cellular fluorescence of the endogenous photosensitizer protoporphyrin IX following exposure to 5-aminolevulinic acid. Photochem Photobiol 62(5):887-895
32. Zaak D, Karl A, Knuchel R, Stepp H, Hartmann A, Reich O, Bachmann A, Siebels M, Popken G, Stief C (2005) Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy. BJU Int 96(2):217-222
33. Kriegmair M, Baumgartner R, Knuchel R, Stepp H, Hofstadter F, Hofstetter A (1996) Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 155(1):105-109 (discussion 109-110)
34. D'Hallewin MA, Kamuhabwa AR, Roskams T, De Witte PA, Baert L (2002) Hypericin-based fluorescence diagnosis of bladder carcinoma. BJU Int 89(7):760-763
35. Kubin A, Meissner P, Wierrani F, Burner U, Bodenteich A, Pytel A, Schmeller N (2008) Fluorescence diagnosis of bladder cancer with new water soluble hypericin bound to polyvinylpyrrolidone: PVP-hypericin. Photochem Photobiol 84(6):1560-1563
36. Sim HG, Lau WK, Olivo M, Tan PH, Cheng CW (2005) Is photodynamic diagnosis using hypericin better than white-light cystoscopy for detecting superficial bladder carcinoma? BJU Int 95(9):1215-1218
37. Pan Y, Xie H, Fedder GK (2001) Endoscopic optical coherence tomography based on a microelectromechanical mirror. Opt Lett 26(24):1966-1968
38. Fujimoto JG, Pitris C, Boppart SA, Brezinski ME (2000) Optical coherence tomography: An emerging technology for biomedical imaging and optical biopsy. Neoplasia 2(1-2):9-25
39. Zagaynova EV, Shirmanova MV, Kirillin MY, Khlebtsov BN, Orlova AG, Balalaeva IV, Sirotkina MA, Bugrova ML, Agrba PD, Kamensky VA (2008) Contrasting properties of gold nanoparticles for optical coherence tomography: Phantom, in vivo studies and Monte Carlo simulation. Phys Med Biol 53(18):4995-5009
40. Manyak MJ, Gladkova ND, Makari JH, Schwartz AM, Zagaynova EV, Zolfaghari L, Zara JM, Iksanov R, Feldchtein FI (2005) Evaluation of superficial bladder transitional-cell carcinoma by optical coherence tomography. J Endourol 19(5):570-574
41. Goh AC, Tresser NJ, Shen SS, Lerner SP (2008) Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer. Urology 72(1):133-137
42. Wang ZG, Durand DB, Schoenberg M, Pan YT (2005) Fluorescence guided optical coherence tomography for the diagnosis of early bladder cancer in a rat model. J Urol 174(6):2376-2381
43. Gono K, Obi T, Yamaguchi M, Ohyama N, Machida H, Sano Y, Yoshida S, Hamamoto Y, Endo T (2004) Appearance of enhanced tissue features in narrow-band endoscopic imaging. J Biomed Opt 9(3):568-577
44. Yoshida T, Inoue H, Usui S, Satodate H, Fukami N, Kudo SE (2004) Narrow-band imaging system with magnifying endoscopy for superficial esophageal lesions. Gastrointest Endosc 59(2):288-295
45. Machida H, Sano Y, Hamamoto Y, Muto M, Kozu T, Tajiri H, Yoshida S (2004) Narrow-band imaging in the diagnosis of colorectal mucosal lesions: A pilot study. Endoscopy 36(12):1094-1098
46. Bryan RT, Billingham LJ, Wallace DM (2008) Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder. BJU Int 101(6):702-705 (discussion 705-706)
47. Herr HW, Donat SM (2008) A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences. BJU Int 102(9):1111-1114
48. Fenlon HM, Bell TV, Ahari HK, Hussain S (1997) Virtual cystoscopy: Early clinical experience. Radiology 205(1):272-275
49. Yazgan C, Fitoz S, Atasoy C, Turkolmez K, Yagci C, Akyar S (2004) Virtual cystoscopy in the evaluation of bladder tumors. Clin Imaging 28(2):138-142
50. Tsampoulas C, Tsili AC, Giannakis D, Alamanos Y, Sofikitis N, Efremidis SC (2008) 16-MDCT cystoscopy in the evaluation of neoplasms of the urinary bladder. AJR Am J Roentgenol 190(3):729-735
51. Kim JK, Ahn JH, Park T, Ahn HJ, Kim CS, Cho KS (2002) Virtual cystoscopy of the contrast material-filled bladder in patients with gross hematuria. AJR Am J Roentgenol 179(3):763-768
52. Narumi Y, Kumatani T, Sawai Y, Kuriyama K, Kuroda C, Takahashi S, Kim T, Tsuda K, Murakami T, Nakamura H (1996) The bladder and bladder tumors: imaging with three-dimensional display of helical CT data. AJR Am J Roentgenol 167(5):1134-1135
53. Tsili A, Tsampoulas C, Chatziparaskevas N, Silakos A, Kalef-Ezra J, Sofikitis N, Efremidis SC (2004) Computed tomographic virtual cystoscopy for the detection of urinary bladder neoplasms. Eur Urol 46(5):579-585